Market revenue in 2023 | USD 798.1 million |
Market revenue in 2030 | USD 1,114.7 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Liquid delivery device |
Fastest growing segment | Powder delivery device |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler |
Key market players worldwide | GSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.
Liquid delivery device was the largest segment with a revenue share of 43.79% in 2023. Horizon Databook has segmented the Saudi Arabia intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.
Ministry of Health is the main organization responsible for maintaining healthcare services in Saudi Arabia. Healthcare insurance is provided by both government and private entities. Companies operating in Saudi Arabia are likely to gain significant share of the market due to increasing usage of intranasal drug and vaccine delivery devices for chronic disorders.
Moreover, high rate of urbanization in some parts of Mecca, Riyadh, and the Eastern Province is creating huge growth opportunities for market players. Thus, urbanization and increase in the number of intranasal drug and vaccine delivery devices are expected to boost market growth in Saudi Arabia over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia intranasal drug and vaccine delivery market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account